+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway



Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway



Neuropharmacology 65: 48-57



Partial lesion (50%) of the nigro-striatal dopaminergic pathway induces compensatory increase in dopamine release from the remaining neurons and increased extracellular oxidative stress (OS(-ec)) in the striatum. The present study was designed to explore the role of monoamine oxidase types A and B (MAO-A, MAO-B) in producing this increased oxidative stress. Lesion of the dopaminergic pathways in the CNS was produced in rats by intra-cerebroventricular injection of 6-hydroxydopamine (6-OHDA; 250 μg) and striatal microdialysis was carried out 5 weeks later. Striatal OS(ec) was determined by measurement of oxidized derivatives of the marker molecule N-linoleyl-tyrosine. Striatal tissue MAO-A activity was unchanged by 6-OHDA lesion but MAO-B activity was increased by 16%, together with a 45% increase in glial cell content. The selective MAO-B inhibitor rasagiline (0.05 mg/kg s.c. daily for 14 days) did not affect microdialysate dopamine concentration [DA(ec)] in sham-operated rats, but decreased OS(ec) by 30%. In lesioned rats, rasagiline decreased [DA(ec)] by 42% with a 49% reduction in OS(ec). The decrease in [DA(ec)] was reversed by the dopamine D2 receptor antagonist sulpiride (10 mg/kg s.c.). The selective MAO-A inhibitor clorgyline (0.2 mg/kg s.c. daily for 14 days) increased striatal [DA(ec)] by 72% in sham-operated rats with no change in OS(ec). In lesioned rats clorgyline increased [DA(ec)] by 66% and decreased OS(ec) by 44%. Rasagiline and clorgyline were effective to a similar extent in reduction of tissue levels of 7-ketocholesterol and the ratio GSSG/GSH, indicative of reduced intracellular oxidative stress level. This data implies that gliosis in our 6-OHDA animals together with inhibition of glial cell MAO-B by rasagiline causes an increase in local levels of dopamine at the presynaptic receptors, and a reduction in dopamine release (and in [DA(ec)]) by presynaptic inhibition. Moreover, inhibition of MAO-A or MAO-B reduces the enhanced level of oxidative stress in the lesioned striatum, and while both clorgyline and rasagiline reduced DA oxidative metabolism, rasagiline possesses an additional antioxidant property, not only that resulting from MAO inhibition.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036626954

Download citation: RISBibTeXText

PMID: 22982254

DOI: 10.1016/j.neuropharm.2012.08.023


Related references

The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions. Neurochemical Research 19(2): 153-159, 1994

Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion. Journal of Neurochemistry 95(1): 79-88, 2005

Localization of rat striatal monoamine oxidase activities towards dopamine, serotonin and kynuramine by gradient centrifugation and nigro-striatal lesions. Life Sciences 33(7): 615-623, 1983

Modifications in electro physiological and pharmacological neuronal properties of the dopaminergic nigro striatal pathway after specific striatal efferents destruction. Neuroscience Letters (Suppl. 7): S130, 1981

Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule. Free Radical Research 44(6): 635-644, 2010

Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B). Experimental and Toxicologic Pathology 65(1-2): 153-158, 2013

Influence of Selective Inhibition of Monoamine Oxidase A or B on Striatal Metabolism of L-DOPA in Hemiparkinsonian Rats. Journal Of Neurochemistry. 65(3): 1213-1220, 1995

The inhibition of vesicular monoamine transporter 2 partially reduces the toxicity of 6-hydroxydopamine on nigro-striatal dopamine neurons. Society for Neuroscience Abstracts 27(1): 1148, 2001

Exogenous l-DOPA induce no dopamine immuno-reactivity in striatal astroglias and microglias of adult rats with extensive nigro-striatal dopaminergic denervation. Neuroscience Letters 433(3): 255-258, 2008

Dopamine release and dopaminergic inhibition of acetylcholine release in rat striatal slices after nigro-striatal hemitransection and parenteral ganglioside administration. European Journal of Pharmacology 213(1): 17-24, 1992

Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. Nature: New Biology 245(144): 150-151, 1973

Effect of systemic and intra striatal injections of haloperidol on striatal dopamine and di hydroxyphenyl acetic acid concentrations in rats pre treated by section of nigro striatal fibers. Journal Of Pharmacy & Pharmacology: 507-510, 1980

Biochemical properties of nigro striatal dopaminergic neurons following intra striatal administration of kainic acid. Pharmacologist 19(2): 223, 1977

Inhibitory influence of nigro striatal dopaminergic neurons on cortico striatal glutamatergic activity in the rat striatum. Neuroscience Letters (Suppl. 14): S261, 1983

Activation of a dopaminergic nigro-striatal pathway. Journal of Physiology 197(1): 20p-21p, 1968